scispace - formally typeset
H

Hiroshi Yoshikura

Researcher at University of Tokyo

Publications -  118
Citations -  3810

Hiroshi Yoshikura is an academic researcher from University of Tokyo. The author has contributed to research in topics: Virus & Murine leukemia virus. The author has an hindex of 29, co-authored 113 publications receiving 3772 citations.

Papers
More filters
Journal ArticleDOI

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses.

TL;DR: The results suggest that HCV does induce antivirion antibody, as measured by blocking of initiation of the replication cycle of virus in cells and by the formation of immunoprecipitable antigen-antibody complexes but that these antibodies are isolate specific and change over time.
Journal ArticleDOI

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.

TL;DR: Examination of serial sera from a chimpanzee infected with HCV revealed parallel changes in the buoyant density and immunoprecipitability of HCV-associated RNA during the course of infection, suggesting that HCV is bound to anti-HCV antibodies as antigen-antibody complexes in chronic hepatitis C.
Journal ArticleDOI

Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line.

TL;DR: It appears likely that the HCV genome can replicate in the human T-cell line MOLT-4, and immunofluorescence tests with antibodies specific for HCV core and NS4 antigens showed that MOLt-4 Ma cells were positive for viral antigen 7 days after inoculation.
Journal ArticleDOI

Detection and Typing of Multiple Genital Human Papillomaviruses by DNA Amplification with Consensus Primers

TL;DR: The sensitivity in detecting HPV DNA was even better than that obtained by using Southern blot analysis, and the PCR with the consensus primers for LI region (Ll‐PCR) could amplify at least nine genital HPV types and could be typed by subsequent restriction mapping.
Journal ArticleDOI

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

TL;DR: The study demonstrated that neutralization of HCV was mediated, in part, by isolate-specific antibody recognizing HVR1, a principal neutralization epitope within the putative envelope of hepatitis C virus.